First-In-Human Trial of 64Cu-Sartate PET Imaging of Patients With Neuroendocrine Tumours Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide Therapy

Journal of Nuclear Medicine - China
doi 10.2967/jnumed.118.217745

Related search